| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2009 | 2008 | 2007 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 531,4 k € | +9.4% | 485,8 k € | +57.3% | 308,9 k € | |||||||||||||||
| Gross margin | 1,4 M € | -17.0% | 1,6 M € | -21.7% | 2,1 M € | +73.0% | 1,2 M € | +72.5% | 701,8 k € | +4.9% | 669,0 k € | -21.4% | 851,1 k € | -17.9% | 1,0 M € | +18.2% | 876,7 k € | -23.9% | 1,2 M € | +11.7% | 1,0 M € | +27.8% | 807,6 k € | -55.0% | 1,8 M € | +202.9% | 592,1 k € | +622.5% | 81,9 k € | -35.6% | 127,1 k € | +50.8% | 84,3 k € | |
| EBITDA | 505,8 k € | -30.2% | 725,0 k € | -44.6% | 1,3 M € | +168.4% | 487,3 k € | +3846.3% | 12,3 k € | +115.5% | -79,4 k € | -148.5% | 163,8 k € | -61.8% | 429,3 k € | +6.5% | 403,2 k € | -22.6% | 521,1 k € | +36.4% | 382,0 k € | +40.9% | 271,1 k € | -81.4% | 1,5 M € | +188.1% | 506,8 k € | +3638.4% | 13,6 k € | -72.7% | 49,6 k € | +138.0% | 20,8 k € | |
| Operating profit | 484,3 k € | -37.6% | 775,8 k € | -40.4% | 1,3 M € | +168.6% | 484,5 k € | +3465.2% | -14,4 k € | +84.6% | -93,2 k € | -162.6% | 148,9 k € | -64.9% | 424,5 k € | +6.9% | 397,3 k € | +7.6% | 369,2 k € | +65.9% | 222,6 k € | +22.9% | 181,1 k € | -86.2% | 1,3 M € | +279.3% | 347,3 k € | +4468.2% | 7,6 k € | -82.2% | 42,8 k € | +321.9% | 10,1 k € | |
| Profit/loss | 413,4 k € | -36.6% | 652,2 k € | +1.5% | 642,4 k € | +76.1% | 364,7 k € | +4399.1% | 8,1 k € | +107.6% | -107,1 k € | -218.3% | 90,6 k € | -65.1% | 259,8 k € | +0.7% | 258,1 k € | -31.4% | 376,4 k € | +193.9% | -400,9 k € | -3395.0% | 12,2 k € | -98.9% | 1,1 M € | +451.1% | 195,3 k € | +18238.7% | 1,1 k € | -96.0% | 26,8 k € | +287.3% | 6,9 k € | |
| Equity | 4,0 M € | +11.7% | 3,5 M € | +22.6% | 2,9 M € | +28.6% | 2,2 M € | +19.4% | 1,9 M € | -1.1% | 1,9 M € | -5.5% | 2,0 M € | +4.5% | 1,9 M € | +15.3% | 1,7 M € | +17.9% | 1,4 M € | +35.5% | 1,0 M € | -28.0% | 1,5 M € | +5.0% | 1,4 M € | +350.8% | 306,8 k € | +373.8% | 64,7 k € | +1.7% | 63,7 k € | +72.5% | 36,9 k € | |
| Total assets | 6,4 M € | +7.8% | 6,0 M € | +12.0% | 5,3 M € | -12.7% | 6,1 M € | +40.6% | 4,3 M € | -5.6% | 4,6 M € | -25.0% | 6,1 M € | -0.5% | 6,2 M € | +6.9% | 5,8 M € | +93.4% | 3,0 M € | -6.0% | 3,2 M € | -10.0% | 3,5 M € | -2.5% | 3,6 M € | +204.3% | 1,2 M € | +404.7% | 235,2 k € | +37.9% | 170,6 k € | +12.9% | 151,2 k € | |
| Cash | 2,1 M € | +260.5% | 590,9 k € | -67.2% | 1,8 M € | -39.2% | 3,0 M € | +75.4% | 1,7 M € | +1.5% | 1,7 M € | +7.0% | 1,6 M € | -25.8% | 2,1 M € | +131.2% | 908,5 k € | +49.3% | 608,7 k € | -29.6% | 864,8 k € | +53.4% | 563,7 k € | -51.5% | 1,2 M € | +997.0% | 105,9 k € | +33.2% | 79,5 k € | +23.2% | 64,6 k € | -27.6% | 89,2 k € | |
| Debts | 2,2 M € | +1.6% | 2,1 M € | -4.5% | 2,2 M € | -41.0% | 3,8 M € | +59.7% | 2,4 M € | -6.3% | 2,5 M € | -36.2% | 4,0 M € | +15.3% | 3,4 M € | +107.3% | 1,7 M € | +35.9% | 1,2 M € | -28.0% | 1,7 M € | +40.0% | 1,2 M € | -37.8% | 1,9 M € | +133.2% | 835,4 k € | +394.4% | 169,0 k € | +58.0% | 106,9 k € | -6.4% | 114,3 k € | |
| Staff | 9,5 | 10 | 7 | 7,8 | 8,7 | 9,7 | 9,4 | 7,4 | 6,3 | 7,6 | 7,9 | 6,7 | 4,5 | 1,2 | 1,4 | 1,8 | 2,8 | |||||||||||||||||
Private limited company profitable and well capitalised. Cash position rising (+260.5%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
OPTIMIZED RADIOCHEMICAL APPLICATIONS is a Private limited company incorporated in 2006. Its main activity is: Manufacture of medical and dental instruments and supplies. Its registered office is in Philippeville. It employs on average 9,5 ETP workers (FTE).
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette